CDK4 and breast carcinoma: At last, our data point to a common mechanism used by MDA-MB-468 and HCC1143 basal-like breast cancer cell lines, involving Wnt/ERK/CDK4/6 activation leading to E/M or CSC maintenance and self-renewal combined with inhibition of differentiation.